Developmental programming of TCE induced autoimmune disease
TCE诱导的自身免疫性疾病的发育编程
基本信息
- 批准号:8927709
- 负责人:
- 金额:$ 9.97万
- 依托单位:
- 依托单位国家:美国
- 项目类别:
- 财政年份:2012
- 资助国家:美国
- 起止时间:2012-12-01 至 2016-10-31
- 项目状态:已结题
- 来源:
- 关键词:AccountingAdoptive TransferAdultAdverse effectsAgeAmericanAutoimmune DiseasesAutoimmune HepatitisAutoimmune ProcessAutoimmunityBloodCD4 Positive T LymphocytesCell physiologyChemical ExposureChemicalsChildChlorinated HydrocarbonsCountryDNA MethylationDevelopmentDiseaseDoseEnvironmental PollutantsEnvironmental PollutionEpidemiologyEpigenetic ProcessEtiologyEventExposure toFemaleGene ExpressionGene MutationGenesGenomeGrantHealthHepatitisHumanImmune responseImmune systemIndividualInsulin-Dependent Diabetes MellitusKnock-outKnowledgeLifeLymphocyteMeasuresMediatingMusOrganic ChemicalsPathologyPregnancyPreventionPreventiveRiskRisk FactorsRoleSclerodermaSolventsSymptomsSystemic Lupus ErythematosusT-LymphocyteTestingTherapeuticTimeToxic effectTrichloroethyleneUnited States National Institutes of HealthWater PollutantsWater PollutionWorkWorkplaceautoreactivitybisulfitedrinking waterearly life exposureexperiencegenome-wideliver inflammationmouse modelnovelpollutantpreventprogramspromoterresearch studysuperfund site
项目摘要
DESCRIPTION (provided by applicant): Autoimmune diseases are a widespread human health problem. Preventing these incurable disorders is currently impossible due to our limited knowledge of autoimmune disease etiology. There is evidence that idiopathic autoimmune disease can be triggered by exposure to certain environmental pollutants such as the solvent trichloroethylene (TCE). We have shown that adult MRL+/+ mice exposed to low-level TCE developed autoimmune disease along with "heritable" alterations in CD4+ T cell function associated with DNA methylation. Although adult-only exposure to TCE triggered autoimmune disease, there is evidence that the developing immune system is even more sensitive than the adult immune system to chemical toxicity. Thus, developmental exposure to TCE is likely to augment the autoimmune-promoting effects of adult exposure. It is expected that this effect will be mediated by changes in the DNA methylation of specific effector genes in CD4+ T cells. If these predictions are confirmed it would support the concept that developmental exposure to chemicals at levels previously thought safe can promote autoimmune disease development in adults. These predictions and associated mechanism of action will be tested here in 3 Aims. Aim 1. Determine impact of developmental TCE exposure on adult autoimmune disease. We will test whether autoimmune disease pathology and associated CD4+ T cell alterations are more robust if TCE exposure begins at gestation rather than as an adult. Aim 2. Define TCE-induced epigenetic alterations in CD4+ T cells. Novel genome-scale DNA methylation profiles will identify time- and concentration-dependent gene alterations in CD4+ T cells from the TCE-treated mice. Aim 3. Characterize autoreactivity of CD4+ T cells from TCE-treated mice. CD4+ T cells from TCE-treated MRL+/+ mice will be tested for their ability to generate autoimmune disease following adoptive transfer into lymphocyte-deficient (Rag knockout) MRL+/+ mice. This adoptive transfer experiment will compare the autoreactivity of CD4+ T cells generated from two windows of donor TCE exposure (developmental and adult- only).
描述(由申请人提供):自身免疫性疾病是一种普遍的人类健康问题。由于我们对自身免疫性疾病病因学的了解有限,目前无法预防这些无法治愈的疾病。有证据表明,暴露于某些环境污染物(如溶剂三氯乙烯(TCE))可引发特发性自身免疫疾病。我们已经证明,暴露于低水平TCE的成年MRL+/+小鼠发生自身免疫性疾病,沿着与DNA甲基化相关的CD 4 + T细胞功能的“遗传性”改变。 虽然只有成人暴露于TCE会引发自身免疫性疾病,但有证据表明,发育中的免疫系统对化学毒性比成人免疫系统更敏感。因此,发育期接触三氯乙烯可能会增强成人接触三氯乙烯的自身免疫促进作用。预计这种效应将通过CD 4 + T细胞中特定效应基因的DNA甲基化变化介导。如果这些预测得到证实,它将支持这样一个概念,即以前认为安全的化学物质的发育暴露可以促进成人自身免疫性疾病的发展。这些预测和相关的作用机制将在3个目标中进行测试。目标1.确定发育期TCE暴露对成人自身免疫性疾病的影响。我们将测试如果TCE暴露开始于妊娠期而不是成年期,自身免疫性疾病病理学和相关的CD 4 + T细胞改变是否更稳健。目标2.定义TCE诱导的CD 4 + T细胞表观遗传学改变。新的基因组规模的DNA甲基化谱将确定TCE处理小鼠的CD 4 + T细胞中的时间和浓度依赖性基因改变。目标3.表征TCE处理小鼠的CD 4 + T细胞的自身反应性。将检测TCE处理的MRL+/+小鼠的CD 4 + T细胞过继转移至淋巴细胞缺陷型(Rag敲除)MRL+/+小鼠后产生自身免疫性疾病的能力。该过继转移实验将比较从供体TCE暴露的两个窗口(发育和仅成人)产生的CD 4 + T细胞的自身反应性。
项目成果
期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
数据更新时间:{{ journalArticles.updateTime }}
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ patent.updateTime }}
SARAH J BLOSSOM其他文献
SARAH J BLOSSOM的其他文献
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
{{ truncateString('SARAH J BLOSSOM', 18)}}的其他基金
New Mexico Integrative Science Program Incorporating Research in Environmental Sciences (NM-INSPIRES)
新墨西哥州综合科学计划纳入环境科学研究(NM-INSPIRES)
- 批准号:
10689665 - 财政年份:2022
- 资助金额:
$ 9.97万 - 项目类别:
New Mexico Integrative Science Program Incorporating Research in Environmental Sciences (NM-INSPIRES)
新墨西哥州综合科学计划纳入环境科学研究(NM-INSPIRES)
- 批准号:
10393297 - 财政年份:2022
- 资助金额:
$ 9.97万 - 项目类别:
Developmental Exposures to Arsenic: Pneumonia, Immunity, and Microbiomes (DEAPIM)
砷的发育暴露:肺炎、免疫和微生物组 (DEAPIM)
- 批准号:
10745882 - 财政年份:2022
- 资助金额:
$ 9.97万 - 项目类别:
Developmental Exposures to Arsenic: Pneumonia, Immunity, and Microbiomes (DEAPIM)
砷的发育暴露:肺炎、免疫和微生物组 (DEAPIM)
- 批准号:
10369655 - 财政年份:2021
- 资助金额:
$ 9.97万 - 项目类别:
Epigenetic modulation of CD4+ T cell differentiation and autoimmunity by trichloroethylene
三氯乙烯对 CD4 T 细胞分化和自身免疫的表观遗传调节
- 批准号:
10392944 - 财政年份:2021
- 资助金额:
$ 9.97万 - 项目类别:
Epigenetic modulation of CD4+ T cell differentiation and autoimmunity by trichloroethylene
三氯乙烯对 CD4 T 细胞分化和自身免疫的表观遗传调节
- 批准号:
10115737 - 财政年份:2021
- 资助金额:
$ 9.97万 - 项目类别:
CD4+ T cell-mediated neurotoxicity with continuous trichloroethylene exposure
持续接触三氯乙烯导致 CD4 T 细胞介导的神经毒性
- 批准号:
8755026 - 财政年份:2014
- 资助金额:
$ 9.97万 - 项目类别:
CD4+ T cell-mediated neurotoxicity with continuous trichloroethylene exposure
持续接触三氯乙烯导致 CD4 T 细胞介导的神经毒性
- 批准号:
8926236 - 财政年份:2014
- 资助金额:
$ 9.97万 - 项目类别:
CD4+ T cell-mediated neurotoxicity with continuous trichloroethylene exposure
持续接触三氯乙烯导致 CD4 T 细胞介导的神经毒性
- 批准号:
9067639 - 财政年份:2014
- 资助金额:
$ 9.97万 - 项目类别:
相似海外基金
Time to ATTAC: Adoptive Transfer of T cells Against gp100+ Cells to treat LAM
ATTAC 时间:针对 gp100 细胞的 T 细胞过继转移来治疗 LAM
- 批准号:
10682121 - 财政年份:2023
- 资助金额:
$ 9.97万 - 项目类别:
Phase I clinical trial of adoptive transfer of autologous folate receptor-alpha redirected CAR T cells for ovarian cancer
自体叶酸受体-α重定向CAR T细胞过继转移治疗卵巢癌的I期临床试验
- 批准号:
10576370 - 财政年份:2022
- 资助金额:
$ 9.97万 - 项目类别:
Phase I clinical trial of adoptive transfer of autologous folate receptor-alpha redirected CAR T cells for ovarian cancer
自体叶酸受体-α重定向CAR T细胞过继转移治疗卵巢癌的I期临床试验
- 批准号:
10387023 - 财政年份:2022
- 资助金额:
$ 9.97万 - 项目类别:
Determining mechanisms of enhanced antitumor efficacy of four-day expanded Th17 cells for adoptive transfer
确定用于过继转移的四天扩增 Th17 细胞增强抗肿瘤功效的机制
- 批准号:
10248409 - 财政年份:2019
- 资助金额:
$ 9.97万 - 项目类别:
A phase I clinical study of adoptive transfer of regulatory T cells (Tregs) and low-dose interleukin-2 (IL-2) for the treatment of chronic graft-versus-host disease (GVHD): gene-marking to inform rational combination therapy
调节性 T 细胞 (Treg) 和低剂量白细胞介素 2 (IL-2) 过继转移治疗慢性移植物抗宿主病 (GVHD) 的 I 期临床研究:基因标记为合理的联合治疗提供信息
- 批准号:
nhmrc : GNT1163111 - 财政年份:2019
- 资助金额:
$ 9.97万 - 项目类别:
Project Grants
Determining mechanisms of enhanced antitumor efficacy of four-day expanded Th17 cells for adoptive transfer
确定用于过继转移的四天扩增 Th17 细胞增强抗肿瘤功效的机制
- 批准号:
10462684 - 财政年份:2019
- 资助金额:
$ 9.97万 - 项目类别:
Gene edited lymphoid progenitors for adoptive transfer as a treatment of primary immunodeficiency
基因编辑的淋巴祖细胞用于过继转移作为原发性免疫缺陷的治疗
- 批准号:
398018062 - 财政年份:2018
- 资助金额:
$ 9.97万 - 项目类别:
Research Grants
Overcoming immune suppression in cancer by targeting PSGL-1 in T cells used for adoptive transfer
通过靶向用于过继转移的 T 细胞中的 PSGL-1 克服癌症中的免疫抑制
- 批准号:
9308643 - 财政年份:2017
- 资助金额:
$ 9.97万 - 项目类别:
Overcoming immune suppression in cancer by targeting PSGL-1 in T cells used for adoptive transfer
通过靶向用于过继转移的 T 细胞中的 PSGL-1 克服癌症中的免疫抑制
- 批准号:
9447149 - 财政年份:2017
- 资助金额:
$ 9.97万 - 项目类别:
Targeting Cancer miRNAs by Adoptive Transfer of Programmed B Lymphocytes
通过程序化 B 淋巴细胞的过继转移靶向癌症 miRNA
- 批准号:
8893915 - 财政年份:2014
- 资助金额:
$ 9.97万 - 项目类别:














{{item.name}}会员




